Transcripts Thiogenesis Therapeutics, Corp.

Stocks

Market Closed - Toronto S.E. 15:42:56 2026-08-21 EDT			5-day change	1st Jan Change
0.5100 ^CAD	+2.00%		-7.27%	-21.54%

08-06	Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-13	Thiogenesis Therapeutics Receives Fda Rare Pediatric Disease Designation for Tti-0102 for the Treatment of Leigh Syndrome	CI

No results match your criteria